Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae

Herz

Volumn 25, Issue 2, 2000, Pages 68-72

  Maass, Matthias ^a   Gieffers, Jens ^a   Solbach, Werner ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Arteriosclerosis; Cell culture; Chlamydia pneumoniae; Infection

Indexed keywords

ARTERY ENDOTHELIUM; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BACTERIAL GROWTH; CELL IMMORTALIZATION; CHLAMYDOPHILA PNEUMONIAE; HUMAN; HUMAN CELL; MACROPHAGE; MESENCHYME; MONOCYTE; NONHUMAN;

EID: 0034010148     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00001953     Document Type: Article

References (18)

1. Airenne S, Surcel HM, Alakarppa H, et al. Chlamydia pneumoniae infection in human monocytes. Infect Immun 1999;67:1445-9.
2. Bartels C, Maass M, Bein G, et al. Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary-artery bypass grafts. Circulation 1999;99:879-82.
3. Boman J, Soderberg S, Forsberg J, et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998;178:274-7.
4. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
5. Dechend R, Maass M, Gieffers J, et al. Chlamydia pneumoniae infection induces NF-κB mediated upregulation of tissue factor and PAI-1 expression in vascular smooth muscle and endothelial cells-A potential link to accelerated arteriosclerotic disease. Circulation 1999;100:1369-73.
6. Godzik KL, O'Brien ER, Wang SK, et al. In vitro suceptibility of human vascular cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995;33:2411-4.
7. Jackson LA, Campbell LA, Kuo CC, et al. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176:292-5.
8. Kaukoranta-Tolvanen SS, Laitinen K, Saikku P, et al. Chlamydia pneumoniae multiplies in human vascular endothelial cells in vitro. Microb Pathogenes 1994;16:313-9.
9. Kuo CC, Jackson LA, Campbell LA, et al. Chlamydia pneumoniae (-TWAR). Clin Microbiol Rev 1995;8:451-61.
10. Libby P. Atheroma: more than mush. Lancet 1996;348:Suppl I:s4-7.
11. Maass M, Bartels C, Engel PM, et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998;31:827-32.
12. Maass M, Bartels C, Krüger S, et al. Endovascular presence of Chlamydia pneumoniae is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 1998;140:S25-30.
13. Maass M, Harig U. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am J Clin Pathol 1995;103:141-8.
14. Maass M, Jahn J, Gieffers J, et al. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction. J Infect Dis (in press).
15. Moulder JW. Interaction of Chlamydiae and host cells in vitro. Microbiol Rev 1991;55:143-90.
16. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
17. Ramirez JA, and the Chlamydia pneumoniae/Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary arteriosclerosis. Ann Intern Med 1996;125:979-82.
18. Ziegler-Heitbrock HWL, Thiel E, Fütterer A, et al. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 1988;41:456-61.